Bronchial interleukin-5 and eotaxin expression in nasal polyposis: Relationship with (A)symptomatic bronchial hyperresponsiveness

American Journal of Respiratory and Critical Care Medicine

Volumn 163, Issue 5, 2001, Pages 1226-1232

  Lamblin, C ^a   Bolard, F ^a   Gosset, P ^a   Tsicopoulos, A ^a   Perez, T ^a   Darras, J ^a   Janin, A ^a   Tonne, B A ^a   Hamid, Q ^a   Wallaert, B ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; INTERLEUKIN 5; MESSENGER RNA;

ADULT; ARTICLE; ASTHMA; BRONCHITIS; BRONCHUS BIOPSY; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; NOSE POLYP; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0035038692     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.163.5.2004197     Document Type: Article

References (38)

1. Nasal polyp inflammation: Effect of topical nasal steroid
2. The clinical relationship of nasal polyps to asthma
3. Methacholine sensitivity in nasal polyposis and the effects of polypectomy
4. Sequential evaluation of pulmonary function and bronchial hyperresponsiveness in patients with nasal polyposis
5. Long-term follow-up of pulmonary function in patients with nasal polyposis
6. (A)symptomatic bronchial-hyperresponsiveness and asthma
7. Eosinophilic airway inflammation in nasal polyposis
8. Recombinant human interleukin-5 is a selective activator of human eosinophil function
9. Eosinophil infiltration precedes development of airway hyperreactivity and mucosal exudation after intranasal administration of interleukin-5 to mice
10. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs
11. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse model
12. Effects of an antibody to interleukin-5 in a monkey model of asthma
13. Eotaxin and eosinophil recruitment: Implications for human disease
14. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils
15. Infiltration of eosinophils into the asthmatic airways caused by interleukin-5
16. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma
17. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma: Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells
18. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics
19. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice
20. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin-5 in mice
21. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo
22. The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation in the induction of bronchial hyperreactivity
23. Inhaled methacholine does not influence the cellular composition of bronchoalveolar lavage fluid
24. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
25. Heterogeneity of bronchial asthma: Subpopulations or different stages of the disease
26. Guidelines for methacholine and exercise challenge testing - 1999
27. Lung volumes and forced ventilatory flows: Report working party. Standardization of lung function tests. European community for steel and coal. Official statement of the European Respiratory Society
28. Investigative use of bronchoscopy, lavage and bronchial biopsies in asthma other airways diseases
29. Eosinophils, mast cells, and basophils in induced sputum from patients with seasonal allergic rhinitis and perennial asthma: Relationship to methacholine responsiveness
30. Bronchial responsiveness and airway inflammation in patients with nonallergic rhinitis with eosinophilia syndrome
31. Is asymptomatic bronchial hyperresponsiveness an indication of potential asthma? A two-year follow-up of young students with bronchial hyperresponsiveness
32. Asymptomatic airway hyperresponsiveness: A three-year follow-up
33. + T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic asthmatics)
34. IL-5 synthesis is up-regulated in human nasal polyp tissue
35. GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis
36. Nasal polyposis: Eosinophils and interleukin-5
37. Nasal polyposis: From cytokines to growth
38. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients